Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis

What is it about?

Immunosuppressive therapies are often used in the management of patients with chronic hypersensitivity pneumonitis (CHP). We show that CHP patients who did not receive immunosuppressive therapies have improved survival; and when immunosuppressive therapies are necessary, use of mycophenolate mofetil or azathioprine may decrease the incidence of treatment-emergent adverse events.

Featured Image